Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 250 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Polymorphism Clear all

Conditions: Kidney Cancer
Interventions: molecular genetic technique, polymerase chain reaction, polymorphism analysis; Genetic
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 18 Years
Enrollment: 471 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2004
U.S. locations: 205
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 150 more

Conditions: Genetic Differences of Lipid Metabolism/Healthy Subjects
Interventions: soybean oil and borage oil; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Genetic Polymorphisms, Heart Failure
Interventions: SGLT2 inhibitors (Dapagliflozin and Empagliflozin); Drug
Lead sponsor: October 6 University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Atrial Fibrillation, Deep Vein Thrombosis, Cardiac Valvular Insufficiency, Coagulopathies, Pulmonary Embolism
Interventions: Genotype-guided, Standard-of-Care; Genetic · Other
Lead sponsor: University of Puerto Rico; Other
Eligibility: 21 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Atherosclerotic Vascular Disease, Coronary Arterial Disease (CAD), Atherosclerosis of Coronary Artery, Atherosclerosis of Arteries of the Extremities, Unspecified, Heart Diseases, Stroke, Venous Thromboembolic Disease
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 13,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2026
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Hypercholesterolemia, Myopathy
Interventions: Not listed
Lead sponsor: Genomas, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: San Francisco, California • Hartford, Connecticut • New York, New York

Conditions: Diabetic Retinopathy, Diabetic Macular Edema
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lung Disease, Brain Injury, Necrotizing Enterocolitis, Respiratory Failure
Interventions: Not listed
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Not listed
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Kansas City, Missouri

Conditions: Asthma
Interventions: Not listed
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 4 Years to 18 Years
Enrollment: 193 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Diabetes, Heart Disease, Asthma
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years and older
Enrollment: 9,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Diabetes, Heart Disease, Asthma
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 25,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2010
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Research Triangle Park, North Carolina

Conditions: Neurocognitive Impairment, Acute Lymphoblastic Leukemia
Interventions: Neurocognitive and behavioral evaluation; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 8 Years and older
Enrollment: 237 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Phantom Limb
Interventions: Blood Draw; Procedure
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years and older
Enrollment: 726 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mammography
Interventions: Not listed
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Malaria, Falciparum
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Months to 65 Years
Enrollment: 534 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes
Interventions: CliniMacs TCR alpha-beta-Biotin system; Device
Lead sponsor: Michael Pulsipher; Other
Eligibility: Up to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 11
States / cities: Los Angeles, California • Oakland, California • Palo Alto, California + 8 more

Conditions: Atherosclerosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 1,888 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alzheimer's Disease (AD)
Interventions: lorazepam; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years to 80 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Genetics, Skin Aging
Interventions: Topical Anti Aging Cream; Other
Lead sponsor: HelicalCodeMD; Industry
Eligibility: 21 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Laguna Hills, California

Conditions: Drug Toxicity
Interventions: Blood sampling; Procedure
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: Not listed
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 7
States / cities: Little Rock, Arkansas • Louisville, Kentucky • Detroit, Michigan + 4 more

Conditions: Weight Management, Diet Conditions, Dietary Recommendations, Overweight Management, Obesity
Interventions: Not listed
Lead sponsor: Interleukin Genetics, Inc.; Industry
Eligibility: 25 Years to 50 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Stanford, California

Conditions: Myocardiopathies, Ischemia, Myocardial, Arrythmia, Death, Sudden, Cardiac
Interventions: Not listed
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV-1 Seropositive, Inflammation, Cancer, Cardiomyopathy
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: mutation analysis; Genetic
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

DNA Variations in the Gene in Young Patients With Wilms' Tumor

Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils

Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

DNA Diagnostic System for Statin Safety and Efficacy

Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

The Genetics of Severe Asthma in Children

Environmental Polymorphisms Registry Health and Exposures Survey

Personalized Environment and Genes Study

Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography

Malaria Transmission Studies in Mali

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Genetic Factors in Atherosclerosis

The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms

Relationship of Skin Related SNP to Topical Skin Care Product

Cytokines Polymorphisms and Acetaminophen Toxicity

A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage

Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C